Our research and trials staff are dedicated and experienced professionals, interested in pushing the boundaries of our knowledge and testing new ideas in practical environments. Use the links below to jump to categorised trials.

Type: A randomized trial for adults with newly diagonosed Acute Lymbphoblastic Leukaemia
Eligibility: Newly diagnosed ALL in patients aged 1 to 25 years Patients with B-ALL (Burkitt-like) and Philadelphia-positive ALL are excluded
Study details: Treatment for all patients will consist of a steroid pre-phase followed by 2 phases of induction therapy during which novel agents will be tested (precursor-B-lineage: 2 randomisation arms termed B1 and B2 and T lineage ALL 2 randomisation arms termed T1 and T2)